Amstel Ploos Biography and Net Worth

Director of Zura Bio


Amstel Ploos is the Director of Zura Bio.

What is Amstel Arnout Ploos' net worth?

The estimated net worth of Amstel Arnout Ploos is at least $538.60 thousand as of May 17th, 2024. Ploos owns 100,000 shares of Zura Bio stock worth more than $538,600 as of April 21st. This net worth approximation does not reflect any other investments that Ploos may own. Learn More about Amstel Arnout Ploos' net worth.

How do I contact Amstel Arnout Ploos?

The corporate mailing address for Ploos and other Zura Bio executives is C/O Maples Corporate Services Limited, Po Box 309 Ugland House, Grand Cayman KY1-11. Zura Bio can also be reached via phone at 858-247-0520 and via email at [email protected]. Learn More on Amstel Arnout Ploos' contact information.

Has Amstel Arnout Ploos been buying or selling shares of Zura Bio?

Amstel Arnout Ploos has not been actively trading shares of Zura Bio in the last ninety days. Most recently, on Friday, May 17th, Van Amstel Arnout Ploos bought 80,000 shares of Zura Bio stock. The stock was acquired at an average cost of $6.20 per share, with a total value of $496,000.00. Following the completion of the transaction, the director now directly owns 100,000 shares of the company's stock, valued at $620,000. Learn More on Amstel Arnout Ploos' trading history.

Who are Zura Bio's active insiders?

Zura Bio's insider roster includes Amit Munshi (Director), Kiran Nistala (EVP), Amstel Ploos (Director), and Parvinder Thiara (Director). Learn More on Zura Bio's active insiders.

Are insiders buying or selling shares of Zura Bio?

During the last year, Zura Bio insiders bought shares 1 times. They purchased a total of 2,000,000 shares worth more than $12,500,000.00. The most recent insider tranaction occured on February, 26th when Major Shareholder Ai Biotechnology Llc bought 2,000,000 shares worth more than $12,500,000.00. Insiders at Zura Bio own 22.1% of the company. Learn More about insider trades at Zura Bio.

Information on this page was last updated on 2/26/2026.

Amstel Arnout Ploos Insider Trading History at Zura Bio

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/17/2024Buy80,000$6.20$496,000.00100,000View SEC Filing Icon  
See Full Table

Amstel Arnout Ploos Buying and Selling Activity at Zura Bio

This chart shows Van Amstel Arnout Ploos's buying and selling at Zura Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Zura Bio Company Overview

Zura Bio logo
Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops Tibulizumab, an IgG-scFv bispecific dual-antagonist antibody engineered by the fusion of ixekizumab and tabalumab that neutralizes IL-17A and BAFF, which is in Phase 2 clinical trial development; ZB-168, a monoclonal antibody that binds and neutralizes the IL-7 receptor chain that impact on diseases driven by IL7 and thymic stromal lymphopoietin immune pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in Henderson, Nevada.
Read More

Today's Range

Now: $5.27
Low: $5.22
High: $5.46

50 Day Range

MA: $6.17
Low: $5.37
High: $7.04

2 Week Range

Now: $5.27
Low: $0.98
High: $7.44

Volume

209,813 shs

Average Volume

663,168 shs

Market Capitalization

$499.54 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.24